• PART 1 - THE BASICS: Myths and Facts: Why Current Practice Fails

    Part 1
    Dr. Glenn Murphy
    20 minutes
    Welcome to this webinar series presented by the Association of Anaesthetists of Great Britain and Ireland on Neuromuscular Blockade (NMB) Monitoring: Enhancing Clinical Practice. This webinar was sponsored by GE Healthcare.

    In this first part, Dr. Glenn Murphy focuses on myths and facts related to neuromuscular management and the reasons why current practices fail.
  • PART 2 - THE MONITORS: Quantitative; Acceleromyography (AMG), Electromyography (EMG), Kinemyography (KMG)

    Part 2
    Dr. J. Ross Renew
    20 minutes
    Welcome to this webinar series presented by the Association of Anaesthetists of Great Britain and Ireland on Neuromuscular Blockade (NMB) Monitoring: Enhancing Clinical Practice. This webinar was sponsored by GE Healthcare.

    In this second part, Dr. J. Ross Renew presents the practical approach of the different kinds of quantitative monitors available in the market today.
  • PART 3 - THE CONSEQUENCES: Respiratory and Other Systems

    Part 3
    Prof. Lars I Eriksson, MD, PhD, FRCA
    20 minutes
    Welcome to this webinar series presented by the Association of Anaesthetists of Great Britain and Ireland on Neuromuscular Blockade (NMB) Monitoring: Enhancing Clinical Practice. This webinar was sponsored by GE Healthcare.

    In this third part, Prof. Lars Eriksson focuses on why should patients be monitored, the impact of NMBA´s on the respiratory system and the clinical consequences of residual neuromuscular block.
  • PART 4 - THE STRATEGY: Putting It All Together; Planning, Monitoring, Drugs

    Part 4
    Dr Grant Rodney, Prof Sorin J. Brull, MD, FCARCSI (Hon)
    20 minutes
    Welcome to this webinar series presented by the Association of Anaesthetists of Great Britain and Ireland on Neuromuscular Blockade (NMB) Monitoring: Enhancing Clinical Practice. This webinar was sponsored by GE Healthcare.

    In this fourth part, Prof. Sorin J Brull and Dr. Grant Rodney present the strategy that may be used when utilizing Neuromuscular Blocking Agents.
  • PART 5 - Q&A: Neuromuscular Blockade (NMB) Monitoring

    Part 5
    Dr Grant Rodney, Dr. Glenn Murphy, Dr. J. Ross Renew, Prof. Lars I Eriksson, MD, PhD, FRCA, Prof Sorin J. Brull, MD, FCARCSI (Hon)
    20 minutes
    Welcome to this webinar series presented by the Association of Anaesthetists of Great Britain and Ireland on Neuromuscular Blockade (NMB) Monitoring: Enhancing Clinical Practice. This webinar was sponsored by GE Healthcare.

    In this last part, Dr. Rodney, Dr. Murphy, Dr. Renew, Prof. Eriksson and Prof. Brull participate in a Q&A session that covers the whole webinar series.
webinar series

Neuromuscular Blockade (NMB) Monitoring

Since 1932 the Association of Anaesthetists of Great Britain and Ireland  has worked to promote safety in anaesthesia and to develop best practice in the specialty.

In this webinar series, various key opinion leaders provide clinical insights on how to optimize the use of neuromuscular blocking agents and improve patient safety.

5 parts